Patent Assignment
Reel/Frame 049221/0673
Supplemental Security Agreement
Recorded: 2019-05-20
Pages: 14
Assignors
R.P. SCHERER TECHNOLOGIES, LLC
Executed: 2019-05-17
CATALENT PHARMA SOLUTIONS, LLC
Executed: 2019-05-17
REDWOOD BIOSCIENCE, INC.
Executed: 2019-05-17
Assignee
JPMORGAN CHASE BANK, N.A.
4 CHASE METROTECH CENTER, MC: NY1-C413, BROOKLYN, NEW YORK, 11245-0001
Covered Properties
(39)
Allergen Dosage Form
Process to Minimize Polymorphism
Application:
12/393,584 →
Publication:
US 2009/0226522
Antibody Libraries
Molded Container with Opener and Method for Use
Oral Solid Dosage Form Containing Nanoparticles and Process of Formulating the Same Using Fish Gelatin
Fusion Antibodies
Process of Manufacturing a Lyophilized Fast Dissolving, Multi-Phasic Dosage Form
Chemical Modification of Proteins
Process of Manufacturing a Stable Softgel Capsule Containing Microencapsulated Probiotic Bacteria
Oral Vaccine Fast-Dissolving Dosage Form Using Starch
Decorin Compositions and Use Thereof
Application:
13/419,045 →
Publication:
US 2012/0238727
Non-Gelatin Soft Capsule System
Automated Sterilization Process Integrated with a Blow Fill Seal Machine
Antibody Specific for CD22 and Methods of Use Thereof
Veterinary Decorin Compositions and Use Thereof
Allergen Dosage Form
Single Use Container with Dispenser
Encased-Pellet Tablets
Hydrazinyl-Pyrrolo Compounds and Methods for Producing a Conjugate
Stable Montelukast Solution
Automated Sterilization Process Integrated with a Blow Fill Seal Machine
Compounds and Methods for Producing a Conjugate
Anti-Her2 Antibody-Maytansine Conjugates and Methods of Use Thereof
Antibody Specific for CD22 and Methods of Use Thereof
Inverse Blow-Fill-Seal Packaging
Aldehyde-Tagged Protein-Based Drug Carriers and Methods of Use
Activated Formylglycine-Generating Enzymes and Methods of Producing and Using the Same
Hydrazinyl-Indole Compounds and Methods for Producing a Conjugate
Hydrazinyl-Pyrrolo Compounds and Methods for Producing a Conjugate
Aldehyde-Tagged Immunoglobulin Polypeptides and Methods of Use Thereof
Hydrazinyl-Substituted Heteroaryl Compounds and Methods for Producing a Conjugate
Hydrazinyl-Indole Compounds and Methods for Producing a Conjugate
Inverse Blow-Fill-Seal Packaging
Application:
15/851,779 →
Publication:
US 2018/0369067
Activated Formylglycine-Generating Enzymes and Methods of Producing and Using the Same
Molded Container with Opener and Method for Use
Application:
16/108,394 →
Publication:
US 2018/0354688
Anti-HER2 Antibody-Maytansine Conjugates and Methods of Use Thereof
Hydrazinyl-Substituted Heteroaryl Compounds and Methods for Producing a Conjugate
Antibody Specific for CD22 and Methods of Use Thereof
Application:
16/289,177 →
Publication:
US 2019/0352395
Charging Fixture with Valves
Patent:
603,525 →
Application:
29/326,079 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 027291 Frame: 0081. Assignor(S) Hereby Confirms the Assignment .
Mar 12, 2018
From: TIAN, WEI; MCLAUGHLIN, ROSIE
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 045558/0610 →
Change of Address of Assignee
Oct 30, 2018
From: R.P. SCHERER TECHNOLOGIES, LLC
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 047364/0237 →
Change of Name
Aug 29, 2019
From: R.P. SCHERER TECHNOLOGIES, INC.
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 050897/0614 →
Assignment of Assignor's Interest
Jan 27, 2020
From: R.P. SCHERER TECHNOLOGIES, LLC
To: CATALENT U.K. SWINDON ZYDIS LIMITED
Reel/Frame 051634/0928 →
Partial Release of Security Interest
Mar 23, 2021
From: JPMORGAN CHASE BANK, N.A.
To: R.P. SCHERER TECHNOLOGIES, LLC (F/K/A R.P. SCHERER TECHNOLOGIES, INC.); CATALENT PHARMA SOLUTIONS, LLC; CATALENT USA WOODSTOCK, INC. (FORMERLY KNOWN AS CARDINAL HEALTH 400, INC.)
Reel/Frame 055681/0049 →
Patent Security Agreement
Mar 31, 2021
From: CATALENT USA WOODSTOCK, INC.
To: CERBERUS BUSINESS FINANCE AGENCY, LLC, AS THE COLLATERAL AGENT
Reel/Frame 055778/0019 →
Assignment of Assignor's Interest
Apr 5, 2021
From: CATALENT PHARMA SOLUTIONS, LLC; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT PHARMA SOLUTIONS, INC.
To: WOLVERINE BIOSCIENCES, LLC
Reel/Frame 055821/0051 →
Patent Security Agreement
Apr 9, 2021
From: WOLVERINE BIOSCIENCES, LLC
To: CERBERUS BUSINESS FINANCE AGENCY, LLC, AS COLLATERAL AGENT
Reel/Frame 055886/0460 →
Merger
Apr 19, 2021
From: WOLVERINE BIOSCIENCES, LLC
To: WOODSTOCK STERILE SOLUTIONS, INC.
Reel/Frame 055955/0975 →
Assignment of Assignor's Interest
Apr 12, 2022
From: R.P. SCHERER TECHNOLOGIES, LLC
To: WOLVERINE BIOSCIENCES, LLC
Reel/Frame 059566/0909 →
Security Interest
Dec 19, 2024
From: CATALENT CTS (KANSAS CITY), LLC; REDWOOD BIOSCIENCE, INC.; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT WELLNESS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069743/0458 →
Release of Security Interest in Patent Collateral (049221/0673)
Dec 19, 2024
From: JPMORGAN CHASE BANK, N.A.
To: CATALENT PHARMA SOLUTIONS, LLC; R.P. SCHERER TECHNOLOGIES, INC.; R.P. SCHERER TECHNOLOGIES, LLC; REDWOOD BIOSCIENCE, INC.
Reel/Frame 069751/0100 →